CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Herrmann et al. demonstrated that the phenotype of CML-LSCs was CD34+CD38−CD26+, and that CD26+ was a novel feature between normal stem cells and CML-LSCs [15].